The optimal therapy for active inflammatory bowel disease (IBD) is individualized according to the severity and the location of the disease and furthermore, the particular needs of each patient. For ulcerative colitis (UC), topical therapy can be useful in distal disease and the higher the dose...
Thus, inflammatory bowel disease (IBD) may increase the risk of AF. We therefore investigated the risk of AF in patients with IBD in a Danish nationwide cohort. Methods: We included all incident patients with IBD from 1996-2011. Each IBD patient was matched by age and sex with ten ...
目的:研究活动期与缓解期炎症性肠病(IBD)患者粪便主要菌群的改变。方法:收集29例正常对照(HC)、41例活动期克罗恩病(CD)(ACD)、53例缓解期CD(RCD)、60例活动期溃疡性结肠炎(UC)(AUC)以及20例缓解期UC(RUC)患者的粪便标本。采用实时定量PCR检测粪便主要菌群的数量。结果:健康
Potential viral pathogenic mechanism for new variant inflammatory bowel disease Aims: A new form of inflammatory bowel disease (ileocolonic lymphonodular hyperplasia) has been described in a cohort of children with developmental disord... LM Wakefield,L Pilkington,IMC Martin,... - 《Child Care ...
An agent for the prevention and treatment of inflammatory bowel disease (IBD) containing at least one of zinc L-carnosine salts and complexes as an active ingredient. A use of the zinc L-carnosine salts or complexes and a therapeutic method of IBD by using the same are also disclosed.收藏...
The aim of the current study was to determine whether this method could be applied to identify inflammatory activity in ulcerative colitis and Crohn disease in children.Thirty-six children (18 of whom had active disease) with inflammatory bowel disease localized to the colon were studied. The ...
Inflammatory bowel disease (IBD) is often associated with malnutrition. The aim of this study was to compare the body composition of outpatients with IBD during remission and active phase. In order to evaluate disease activity we used Crohn's Disease Activity Index for Crohn's disease (CD) pati...
F. Nanoparticle-based imaging of inflammatory bowel disease. Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2016, 8, 300–315. Google Scholar Shivashankar, R.; Lichtenstein, G. R. Mimics of inflammatory bowel disease. Inflamm. Bowel Dis. 2018, 24, 2315–2321. Article Google Scholar ...
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study. Aliment Pharmacol Ther. 2016; 44(11-12):1199-1212.Stallmach A, Langbein C, Atreya R, ... A Stallmach,C Langbein,R Atreya,... - 《Alimentary...
(1) 2-chlorophenyl] ethyl-1,3-propanediol hydrochloride), or pharmaceutically acceptable salts and hydrates thereof are inflammatory bowel disease Crohn's disease, colonic Crohn's disease, intestinal Behcet's disease, ulcerative colon It was found useful as a therapeutic or prophylactic agent for ...